VEGFA and cancer: High level expression of IL-6 and VEGF and survivin are characterized by increasing survival and proliferation in EOC cells that express TLR4/MyD88, suggesting that activation of this pathway in EOC cells maintain chronic inflammation and promote cancer growth, metastasis and paclitaxel chemoresistance.